Option chain shows key data for ATA Creativity Glb's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for ATA Creativity Glb.

ATA Creativity Glb (NASDAQ:AACG) Stock, Option Chain

ATA Creativity Glb

ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments are Overseas art study services, Other educational services and K-12 education assessment and other services. Majority of its revenue comes from Overseas art study services.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AACG

ACRS

ADIL

ALLK

AMAM

ANEB

ANGH

ARIS

ASLE

BPTS

CARA

CVGW

DOMO

ENFN

ENTX

Euda Health Holdings Limited - Ordinary Shares

EUDA

FRGT

FSTX

GAIA

GGAA

GNLX

INTZ

IONM

JOBY

LODE

NGMS

NTNX

NVOS

OBSV

PROK

PTGX

QUOT

RIVN

SEAT

SWIM

TDUP

TRKA

TRMR

UNCY

VLON

VRAX

ZVRA

ZYXI

Gainers


	Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the European market.


Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Pre-Market Outlook

CBIO

GMDA

MVST

NYXH

PXMD

SLND

XELA

ZEST

Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket

ABBV

ARTL

ARVN

BBBY

BBIG

BCAB

BIVI

BMEA

BPMC

COGT

DNUT

EMBK

ENDP

ENVX

FAZE

FEDU

FPAY

FRZA

FTCH

GDRX

GLBE

GMBL

HSTO

IMAB

ITRM

JCSE

JWEL

KBNT

KIRK

LBPH

LHDX

LMFA

LVLU

LYFT

MRAM

NBSE

NRDY

NVAX

NVFY

OMIC

OPEN

PALI

PAVM

PETZ

PLCE

REAL

SAVA

SDIG

SLNG

SMFR

SNAP

SOND

SPRO

SRAD

TEVA

TLIS

VTGN

This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday

ATA Creativity Global - American Depositary Shares, each representing two common shares

ATA Creativity Global

Select Medical Hldgs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEM#NYSE">SEM</a>) short percent of float has risen 28.95% since its last report. The company recently reported that it has 3.26 million shares sold short, which is 4.9% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Select Medical Hldgs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737143122_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Select Medical Hldgs has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Select Medical Hldgs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Select Medical Hldgs's peer group average for short interest as a percentage of float is 5.24%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Select Medical Hldgs?

Monday.Com's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NYSE">MNDY</a>) short percent of float has risen 10.17% since its last report. The company recently reported that it has 3.02 million shares sold short, which is 7.26% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.5 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Monday.Com Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737143117_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Monday.Com has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Monday.Com's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Monday.Com's peer group average for short interest as a percentage of float is 5.17%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

MNDY

(MNDY) - Analyzing Monday.Com's Short Interest

CVS Health's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) short percent of float has fallen 4.64% since its last report. The company recently reported that it has 18.10 million shares sold short, which is 1.44% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.04 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>CVS Health Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737143112_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CVS Health has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing CVS Health's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, CVS Health's peer group average for short interest as a percentage of float is 9.89%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into CVS Health's Recent Short Interest

Scotiabank analyst Cameron Bean upgrades Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) from Sector Perform to Sector Outperform and raises the price target from $105 to $130.

Upgrades

Price Target

Analyst Ratings

Scotiabank Upgrades Expand Energy to Sector Outperform, Raises Price Target to $130

CHRO

Channel Therapeutics Shares Resume Trading

Channel Therapeutics Shares Halted On A Circuit Breaker To The Upside, Stock Now Up 120.8%

Scotiabank analyst Cameron Bean downgrades EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) from Sector Outperform to Sector Perform and lowers the price target from $55 to $54.

Downgrades

Scotiabank Downgrades EQT to Sector Perform, Lowers Price Target to $54

<a href="https://www.benzinga.com/topic/western-digital" target="_blank" rel="noreferrer noopener">Wall Street analysts</a> rerated Western Digital Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) after the company offered several updates on Thursday, including its fourth-quarter results and the departure of its CFO.
Western Digital announced that <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/106040/000119312525007725/d856730d8k.htm" target="_blank" rel="noreferrer noopener">its current CFO</a>, Wissam Jabre, would retire effective Feb. 28, following the planned separation of the company&#8217;s Flash and HDD businesses. Following the transaction, the company will begin a search for a new CFO.
Also Read: <a href="https://www.benzinga.com/25/01/42980720/microsoft-taps-meta-veteran-to-lead-new-coreai-division-plans-shift-from-openai-dependence" target="_blank" rel="noreferrer noopener">Microsoft Launches CoreAI Division: Ex-Meta Exec To Supercharge Copilot And AI Innovations</a>
The company previously announced that Jabre would serve as the CFO of the HDD business post-split alongside Irving Tan as the CEO.
Western Digital announced that it expects second-quarter fiscal 2025 revenues to fall at the mid-point of its prior guided range of $4.20 billion-$4.40 billion, with adjusted EPS to fall at the low end of its previously guided range of $1.75-2.05. Downside is attributed to a more challenging pricing environment in NAND than previously expected.
<ul>
<li>Cantor Fitzgerald analyst C J Muse reiterated Western Digital with an Overweight and a <a target="_blank" href="https://www.benzinga.com/quote/WDC/analyst-ratings" rel="noreferrer noopener">$95&nbsp;price target</a>.</li>
<li>JPMorgan analyst Harlan Sur has no rating on Western Digital.</li>
<li>Barclays analyst Tom O&#8217;Malley maintained Western Digital with an Overweight and lowered the price target from&nbsp;$90&nbsp;to&nbsp;$80.</li>
<li>Benchmark analyst Mark Miller reiterated a Hold rating on Western Digital.</li>
<li>BofA maintained a Buy rating and raised the price target to $84 from $80.</li>
<li>Morgan Stanley analyst Joseph Moore maintained a Buy rating on Western Digital with a price target of $93.</li>
</ul>
Cantor Fitzgerald: Post-close, Western Digital provided several meaningful updates, including an update for fourth-quarter results (revenue at mid-point and EPS at the low end of the prior guide) and the announcement of the departure of the company&#8217;s CFO, who was likely to transition to remain CFO of Western Digital post the NAND asset spin.
Considering the weakening NAND backdrop, the updated guide is likely better than feared by the buy side. This does not mean Western Digital is out of the woods yet, the analyst notes.
Muse sought Western Digital to guide March quarter EPS closer to ~$1.20, with a current consensus of $1.58. Muse looked to update his model after Jan. 29.
The departure of the CFO is more alarming, given expectations for management continuity. The change does not indicate any issues with Western Digital, but rather an opportunity that Wissam could not pass up.
The final takeaway is that the CFO plans to stay until Feb. 28. Thus, a clear clue to the anticipated timing of the spin now is just six weeks away at most. As for shares, Muse senses investors have been waiting for the estimate reset on Jan. 29 before engaging more aggressively on the long side into the SNDK and analyst days scheduled for Feb. 11 and 12 and into the expected share spin in the second half of February.
Muse projected second-quarter revenue of $4.18 billion and EPS of $1.72.
JP Morgan: After the market close yesterday, Western Digital negatively preannounced December quarter results, with revenue expected to land in line with the mid-point of guidance ($4.2 billion-$4.4 billion) while EPS will likely be on the lower end of its previous guided range ($1.75- $2.05) primarily due to a more challenging pricing environment within its NAND business. 
The weaker NAND pricing trends observed by Western Digital should not be a big surprise as the team telegraphed softening NAND pricing at investor conferences in early December, citing elevated inventory levels and sluggish demand in PC, smartphone, and retail, resulting in a few choppy quarters and mid-cycle pause as customers continue to work down excess inventory. 
NAND pricing and demand trends should improve by the September quarter as excess inventory is flushed out, and favorable content tailwinds and adoption of edge AI devices drive renewed NAND memory procurement.
Consistent with what we heard on Micron Technology, Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) earnings call, Sur noted Western Digital is also seeing a temporary pause in eSSD shipments in the first half as demand trends at cloud and data center customers tend to be lumpy. Looking ahead, Sur noted strong AI compute infrastructure demand is driving increased storage demand across both nearline HDD and eSSD in the datacenter end-market and is providing a favorable backdrop for long-term growth and margin expansion.
On the back of weaker pricing trends in NAND, Sur lowered his calendar 2025 estimates. Excess inventory and seasonal headwinds in PC, smartphone, and retail will likely persist through the first half of 2025.
Expect pricing and demand trends in NAND to improve through the back half of 2025. Consumer and cyclical segments of the market will begin to recover, he adds. 
Sur projected second-quarter revenue of $4.25 billion and EPS of $1.75.&nbsp;
Price Action: Western Digital stock is up 2% at $65.54 at last check Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/42960291/metas-content-moderation-changes-alarm-advertisers-as-zuckerberg-aligns-with-trump-and-musk" target="_blank" rel="noreferrer noopener">Meta&#8217;s Content Moderation Changes Alarm Advertisers as Zuckerberg Aligns with Trump and Musk</a></li>
</ul>
Image: Shutterstock

Reiteration

Tech

Western Digital Faces 'Challenging Pricing Environment,' But There's Long-Term Potential: Analysts

Scotiabank analyst Cameron Bean downgrades Range Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) from Sector Outperform to Sector Perform and maintains the price target from $45 to $45.

Scotiabank Downgrades Range Resources to Sector Perform, Maintains Price Target to $45

The <a href="https://www.benzinga.com/topic/fda-0">Food and Drug Administration</a> issued a warning letter to Hologic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>), citing violations in the manufacturing and reporting processes for its BioZorb product line.
The letter, addressed to CEO and President Stephen MacMillan, outlines significant compliance concerns that have prompted the company to discontinue the product.
During an <a href="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hologic-inc-698214-12182024" target="_blank" rel="noreferrer noopener">inspection</a> from July 30 to Sept. 24, 2024, at Hologic&#8217;s Marlborough, Massachusetts, facility, the FDA identified several deficiencies related to the production of BioZorb, a class II implantable radiographic marker.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/10/41554220/hologic-recalls-soft-tissue-marker-device-biozorb-fda-issues-warning-after-almost-400-complaints" rel="noreferrer noopener">Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints</a>
Key violations included failing to establish adequate design control procedures and maintaining quality system regulations.
The FDA highlighted gaps in design input requirements, verification testing, and validation studies, including the inability to confirm that the BioZorb device appropriately meets its intended use or resorbs in soft tissue.
Complaints of malfunction, including cases where the device did not dissolve for nearly five years, were noted as serious concerns.
Despite discontinuing the BioZorb line, the FDA expressed ongoing safety concerns for patients with implanted devices.
Specific risks include cancer detection interference, radiation treatment complications, and incomplete device resorption. Hologic has yet to address these risks adequately for patients who may require intervention or device removal.
The FDA criticized Hologic&#8217;s corrective and preventive action procedures, citing delayed responses to recurring adverse events such as infections, tissue damage, and device migration.
A spike in complaints reported in 2023 went unaddressed until mid-2024, and the company failed to accurately calculate occurrence rates for adverse events.
The letter also flagged lapses in mandatory reporting of adverse events and corrections. Hologic was cited for failing to submit timely Medical Device Reports and corrections under the required timelines.
The FDA has required Hologic to provide a comprehensive corrective action plan within 15 business days, including documentation of steps to prevent future violations.
Failure to comply may result in regulatory actions such as injunctions, product seizures, or civil penalties.
Price Action: HOLX stock is down 0.11% at $69.89 at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43060049/bumbles-big-leadership-change-and-financial-outlook-set-the-stage-for-2025" target="_blank" rel="noreferrer noopener">Bumble&#8217;s Leadership Rewind: Founder Whitney Wolfe Herd To Step Back Into CEO Role</a></li>
</ul>
Photo: Shutterstock

Health Care

General

HOLX

FDA Warns Hologic Over BioZorb Manufacturing Violations

JP Morgan analyst Arun Jayaram maintains Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) with a Overweight and raises the price target from $191 to $195.

FANG

JP Morgan Maintains Overweight on Diamondback Energy, Raises Price Target to $195

Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>) shares are trading higher Friday potentially on continued momentum after the company announced it had regained compliance with <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43042115/nukkleus-shares-are-soaring-after-hours">Nasdaq listing requirements. </a>
What To Know: The strategic acquisition company received notice that it met the required thresholds, resolving prior compliance issues.
To achieve this, Nukkleus implemented a 1-for-8 reverse stock split in October, reducing its outstanding shares from 16.9 million to approximately 2.1 million. With these steps, Nasdaq canceled a hearing initially scheduled for Jan. 21, confirming the company's continued listing.
The resolution marks a turning point for Nukkleus, alleviating concerns about potential delisting and boosting investor confidence in its ability to meet regulatory standards.
NUKK Price Action: Nukkleus shares were up 57.0% at $32.40 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011725&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="525" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17124446/Screenshot-2025-01-17-at-12.43.59-1024x525.png" alt="" class="wp-image-739618" style="width:523px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17124446/Screenshot-2025-01-17-at-12.43.59-1024x525.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17124446/Screenshot-2025-01-17-at-12.43.59-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17124446/Screenshot-2025-01-17-at-12.43.59-768x393.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/17124446/Screenshot-2025-01-17-at-12.43.59.png 1513w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/01/43060894/supreme-court-upholds-tiktok-ban-ahead-of-trumps-inauguration">Supreme Court Upholds TikTok Ban Ahead Of Trump&#8217;s Inauguration: Necessary For &#8216;Well-Supported National Security Concerns&#8217;</a> </li>
</ul>
Image via Shutterstock.

NUKK

Nukkleus Shares Are On The Rise Today: What's Going On?

J.B. Hunt Transport Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) shares dipped on Friday after Wells Fargo cut its price target on the stock <a target="_blank" href="https://www.benzinga.com/quote/jbht/analyst-ratings" rel="noreferrer noopener">from $200 to $190</a>.
Yesterday, the company reported fourth-quarter EPS&nbsp;of $1.53, which missed the consensus of $1.63, while sales&nbsp;of $3.15 billion were in<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43040470/j-b-hunt-transport-services-inc-reports-u-s-gaap-revenues-net-earnings-and-earnings-per-share-for-" rel="noreferrer noopener"> line with the street view</a>.
Operating revenue fell 5% year over year to $3.15 billion due to a 3% and 2% decline in revenue per load excluding fuel surcharge revenue in Intermodal and Truckload segments, respectively, a 4% reduction in average trucks in Dedicated Contract Services and a 22% decrease in load volume in <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">Integrated Capacity Solutions</a>.
Also, JP Morgan cut the price forecast to $200 from $205, while reiterating an Overweight rating.
Evercore ISI Group trimmed the price forecast to $202 from $207, reaffirming an Outperform rating.
Meanwhile, Stifel analyst J. Bruce Chan raised the price forecast to $174 from $161 <a target="_blank" href="https://www.benzinga.com/quote/jbht/analyst-ratings" rel="noreferrer noopener">while maintaining a Hold Rating</a>.
The analyst notes an unexpected $16 million intangible impairment charge, translating to about $0.10 per share.
Intermodal ended 2024 with record volumes, but residual contract pricing from earlier in the year weighed on revenue. The analyst adds that it is expected to remain a headwind until the third quarter of FY25, with only gradual improvement.
The analyst says the Dedicated segment continues to experience fleet contraction, likely persisting into the second quarter of FY25.
Chan writes that management guided first-quarter FY25 margins lower, citing a disconnect between optimistic Street estimates and expectations of inventory pull-forward, projecting a 20% &#8211; 25% sequential decline in operating income.
Overall, the analyst says this quarter had positives but raised concerns about near-term earnings and stock performance.
Chan lowered the first-quarter EPS estimates from $1.46 to $1.15, 2025 from $7.00 to $6.55, and set a 2026 EPS estimate of $8.10.
Benchmark analyst Christopher Kuhn writes that excluding an impairment charge in ICS from the BNSF acquisition, fourth-quarter EPS of $1.66 exceeded expectations owing to slightly better operating income than he expected. The analyst adds that first-quarter guidance is a disappointment.
The analyst says that he continues to consider JBHT&#8217;s diversified model and secular growth in Intermodal and Dedicated could support long-term EPS growth. However, patience may wane as estimates are revised down and mid-cycle earnings continue to get pushed out.&nbsp;&nbsp;
Investors can gain exposure to the stock via ProShares Trust ProShares Supply Chain Logistics ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUPL#NYSE">SUPL</a>) and SPDR S&amp;P Transportation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XTN#NYSE">XTN</a>).
Price Action: JBHT shares are down 6.24% at $174.58 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/43051358/us-stock-likely-to-open-higher-ahead-of-trumps-inaugration-all-11-sectors-to-report-growing-profits-in-2025-says-analyst" target="_blank" rel="noreferrer noopener">US Stocks Likely To Open Higher Ahead of Trump&#8217;s Inaugration: All 11 Sectors To Report Growing Profits In 2025, Says Analyst</a></li>
</ul>
Photo by Ground Picture on Shutterstock.

Analyst Color

Equities

Large Cap

JBHT

ProShares Trust ProShares Supply Chain Logistics ETF

SUPL

J.B. Hunt Q1 Guidance A Disappointment, Analyst Says

DA Davidson analyst Peter Winter maintains M&amp;T Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) with a Neutral and raises the price target from $222 to $223.

DA Davidson Maintains Neutral on M&T Bank, Raises Price Target to $223

Macro Economic Events

Market Summary

Economics

SPDR Dow Jones Industrial Average ETF Trust

Benzinga Market Summary: Indexes Rise Ahead Of Trump Inauguration, Supreme Court Upholds TikTok Law, China Meets 2024 GDP Growth Target

Investors with a lot of money to spend have taken a bullish stance on Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BKNG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 70 uncommon options trades for Booking Holdings.
This isn't normal.
The overall sentiment of these big-money traders is split between 45% bullish and 38%, bearish.
Out of all of the special options we uncovered, 13 are puts, for a total amount of $2,208,876, and 57 are calls, for a total amount of $2,570,119.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $4100.0 and $5800.0 for Booking Holdings, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Booking Holdings options trades today is 160.22 with a total volume of 412.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Booking Holdings's big money trades within a strike price range of $4100.0 to $5800.0 over the last 30 days.
<h3>Booking Holdings Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737142228_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BKNG</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$327.2</td>
<td>$302.2</td>
<td>$313.0</td>
<td>$4100.00</td>
<td>$1.5M</td>
<td align="right">2</td>
<td align="right">50</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$303.0</td>
<td>$285.5</td>
<td>$303.0</td>
<td>$4670.00</td>
<td>$181.8K</td>
<td align="right">25</td>
<td align="right">6</td>
</tr>
<tr>
<td>BKNG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$166.2</td>
<td>$155.0</td>
<td>$155.0</td>
<td>$4550.00</td>
<td>$155.0K</td>
<td align="right">4</td>
<td align="right">10</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$217.0</td>
<td>$200.1</td>
<td>$208.0</td>
<td>$5100.00</td>
<td>$145.6K</td>
<td align="right">19</td>
<td align="right">8</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$270.0</td>
<td>$260.6</td>
<td>$270.0</td>
<td>$4950.00</td>
<td>$108.0K</td>
<td align="right">38</td>
<td align="right">4</td>
</tr>
</tbody>
</table>

<h3>About Booking Holdings</h3>
Booking is the world's largest online travel agency by sales, offering booking and payment services for hotel and alternative accommodation rooms, airline tickets, rental cars, restaurant reservations, cruises, experiences, and other vacation packages. The company operates several branded travel booking sites, including Booking.com, Agoda, OpenTable, and Rentalcars.com, and has expanded into travel media with the acquisitions of Kayak and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.
In light of the recent options history for Booking Holdings, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Booking Holdings</h3>
<ul>
<li>Currently trading with a volume of 170,593, the BKNG's price is up by 1.6%, now at $4942.98. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 34 days.</li>
</ul>
<h3>Expert Opinions on Booking Holdings</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $5242.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo persists with their Equal-Weight rating on Booking Holdings, maintaining a target price of $4470. 
&#x2A; An analyst from Wedbush persists with their Outperform rating on Booking Holdings, maintaining a target price of $5500. 
&#x2A; An analyst from Morgan Stanley persists with their Equal-Weight rating on Booking Holdings, maintaining a target price of $5000. 
&#x2A; An analyst from Mizuho persists with their Outperform rating on Booking Holdings, maintaining a target price of $6000. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Booking Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

BKNG

Unpacking the Latest Options Trading Trends in Booking Holdings

Investors with a lot of money to spend have taken a bearish stance on Bank OZK (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OZK#NASDAQ">OZK</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with OZK, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Bank OZK.
This isn't normal.
The overall sentiment of these big-money traders is split between 20% bullish and 60%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $402,715, and 12 are calls, for a total amount of $2,175,699.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $40.0 to $60.0 for Bank OZK over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Bank OZK's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Bank OZK's substantial trades, within a strike price spectrum from $40.0 to $60.0 over the preceding 30 days.
<h3>Bank OZK Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737142223_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OZK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$8.7</td>
<td>$8.4</td>
<td>$8.4</td>
<td>$40.00</td>
<td>$462.0K</td>
<td>1.9K</td>
<td>556</td>
</tr>
<tr>
<td>OZK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$8.7</td>
<td>$8.4</td>
<td>$8.4</td>
<td>$40.00</td>
<td>$405.6K</td>
<td>1.9K</td>
<td>1.6K</td>
</tr>
<tr>
<td>OZK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.5</td>
<td>$5.2</td>
<td>$5.5</td>
<td>$42.50</td>
<td>$290.9K</td>
<td>981</td>
<td>529</td>
</tr>
<tr>
<td>OZK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$8.7</td>
<td>$8.4</td>
<td>$8.48</td>
<td>$40.00</td>
<td>$252.7K</td>
<td>1.9K</td>
<td>856</td>
</tr>
<tr>
<td>OZK</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$12.1</td>
<td>$10.4</td>
<td>$12.2</td>
<td>$60.00</td>
<td>$183.0K</td>
<td>0</td>
<td>150</td>
</tr>
</tbody>
</table>

<h3>About Bank OZK</h3>
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit and individual retirement accounts to loan services like real estate, consumer, commercial and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking and other related services.
Having examined the options trading patterns of Bank OZK, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Bank OZK</h3>
<ul>
<li>With a trading volume of 2,628,929, the price of OZK is up by 5.76%, reaching $47.95.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 89 days from now.</li>
</ul>
<h3>What The Experts Say On Bank OZK</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $53.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Stephens &amp; Co. lowers its rating to Equal-Weight with a new price target of $53.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Bank OZK, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Market Whales and Their Recent Bets on OZK Options

Investors with a lot of money to spend have taken a bearish stance on Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CCL, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 23 options trades for Carnival.
This isn't normal.
The overall sentiment of these big-money traders is split between 39% bullish and 52%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $57,000, and 22, calls, for a total amount of $1,627,170.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $17.5 to $32.0 for Carnival over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Carnival's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Carnival's whale activity within a strike price range from $17.5 to $32.0 in the last 30 days. 
<h3>Carnival Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737142218_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$7.95</td>
<td>$7.95</td>
<td>$7.95</td>
<td>$17.50</td>
<td>$397.5K</td>
<td>26.0K</td>
<td>519</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.0</td>
<td>$7.95</td>
<td>$8.0</td>
<td>$17.50</td>
<td>$394.4K</td>
<td>26.0K</td>
<td>1.0K</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.65</td>
<td>$5.5</td>
<td>$5.6</td>
<td>$20.00</td>
<td>$112.0K</td>
<td>25.5K</td>
<td>567</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$7.1</td>
<td>$7.05</td>
<td>$7.1</td>
<td>$19.00</td>
<td>$110.0K</td>
<td>8.3K</td>
<td>182</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$4.55</td>
<td>$4.45</td>
<td>$4.45</td>
<td>$25.00</td>
<td>$65.8K</td>
<td>7.3K</td>
<td>1</td>
</tr>
</tbody>
</table>

<h3>About Carnival</h3>
Carnival is the largest global cruise company, with more than 90 ships in service at the end of fiscal 2024. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&amp;O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It's currently folding its P&amp;O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.
In light of the recent options history for Carnival, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Carnival Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 14,963,223, the CCL's price is up by 4.01%, now at $26.05. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 68 days.</li>
</ul>
<h3>Professional Analyst Ratings for Carnival</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $29.333333333333332.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Underweight rating on Carnival, which currently sits at a price target of $22. 
&#x2A; Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on Carnival with a target price of $34. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Carnival with a target price of $32. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Carnival options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Behind the Scenes of Carnival's Latest Options Trends

Royal Caribbean Cruises Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) shares are trading higher on Friday after JPMorgan analyst Matthew R. Boss <a href="https://www.benzinga.com/quote/RCL/analyst-ratings">reiterated a Overweight</a> rating on the shares and raised the price target to $295 from $253.
Cruise demand remains strong, the analyst says. Royal Caribbean management remains focused on &#8220;optimizing&#8221; its booking curve for 2025 and beyond, rather than pursuing &#8220;record&#8221; numbers.
A key strategy for this optimization is the use of artificial intelligence. AI now drives 95% of the 20-25 million price points in the market at any given time. Boss equated the trend to how airlines adjust their fares frequently.
See Also: <a href="https://www.benzinga.com/25/01/43062563/imf-lifts-us-growth-outlook-betting-markets-raise-odds-on-trump-led-economic-boom" target="_blank" rel="noreferrer noopener">IMF Lifts US Growth Outlook, Betting Markets Raise Odds On Trump-Led Economic Boom</a>
The analyst estimates fourth-quarter earnings per share (EPS) at $1.50. That&#8217;s slightly above the Street's $1.49.
There are two key developments suggesting potential upside for onboard spending. First an increase in onboard spending each quarter throughout the year and booking trends improved during the quarter, with 2025 booking volumes exceeding last year's, noted the analyst.
&#8220;To this point, RCL is a share gainer in the $1.9 trillion global vacation market, which is estimated to grow at ~4% annually with RCL at only ~1% share today,&#8221; the analyst notes.
Currently, Royal Caribbean holds just about 1% of this market, while the cruise sector accounts for approximately 3-4%.
A major point of focus, the analyst says, for the upcoming analyst day is management&#8217;s goal of achieving a roughly 50% spread between yields and costs, &#8220;net&#8221; of reinvestments in growth initiatives, which will set the stage for future expansion.
Analysts expect Royal Caribbean&#8217;s strategy of moderate yield growth combined with strong cost control to result in approximately 210 basis points of annual EBITDA margin expansion, reaching 47.8% by 2027 or around 600 basis points higher than 2019 levels.
Finally, the analyst views the company as a top-tier player in its sector due to its industry-leading net promoter scores, competitive portfolio of destinations, including Perfect Day at Cococay, which rivals land-based options, stronger cost discipline compared to its competitors, and ability to reduce leverage through EBITDA growth and free cash flow generation.
Price Action: Royal Caribbean shares are trading higher by 3.64% at $241.65 on the last check Friday.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43064144/wall-street-roars-ahead-of-trumps-inauguration-intel-rallies-bitcoin-tops-105000-whats-driving-markets-friday">Wall Street Roars Ahead Of Trump&#8217;s Inauguration, Intel Rallies, Bitcoin Tops $105,000: What&#8217;s Driving Markets Friday?</a></li>
</ul>
Image Courtesy: Royal Caribbean Cruises

Travel

Royal Caribbean Shares Rise Friday, Analyst Calls Cruise Stock 'A Share Gainer' In $2 Trillion Vacation Industry

Barrington Research analyst Alexander Paris maintains Adtalem Glb Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATGE#NYSE">ATGE</a>) with a Outperform and raises the price target from $95 to $115.

Adtalem Global Education Inc. Common Stock

ATGE

Barrington Research Maintains Outperform on Adtalem Glb Education, Raises Price Target to $115

ATA Creativity Global (AACG) has released an update. ATA Creativity Global (ACG) reported a substantial increase in student enrollment and credit h...

ATA Creativity Global Shows Strong Q2 Growth

ATA Creativity Global 2024 Q2 - Results - Earnings Call Presentation

ATA Creativity Global (AACG) Q2 2024 Earnings Call Transcript

ATA Creativity Global (AACG) has released an update. ATA Creativity Global will conduct its annual general meeting virtually on December 3, 2024, a...

ATA Creativity Global Announces Virtual Shareholder Meeting

Comments

ATA Creativity Glb

ATA Creativity Glb (AACG) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga